The company intends to focus on custom partnerships around stroke, cancer, cardiovascular diseases and neurodegenerative diseases.

At the Association for Molecular Pathology annual meeting in Boston, stakeholders discussed regulatory and legislative priorities for the coming year.

Last week, readers were most interested in a story about Labcorp's acquisition of certain lab assets of Parkview Health, which serves patients in Indiana and northwest Ohio.

Given the amount of tests that have required certification under the new system, the EU has staggered the grace periods for different classes of devices already holding CE-IVD marks obtained under the ...

Labcorp will acquire outreach labs serving patients in Indiana and northwest Ohio while Parkview will continue to operate labs serving acute and emergency needs.

The updated CE marking now enables labs in Europe to unify their workflows for both cell and tissue slide imaging and processing.

NEW YORK – Sera Prognostics on Thursday afternoon reported a 45 percent year-over-year decline in third quarter revenues. For the quarter ended Sept. 30, the Salt Lake City-based maternal and neonatal ...

Revenues from the Life Sciences business unit, which is on track to be sold to Waters in Q1 2026, rose 2 percent to $1.37 billion.

Designed for routine clinical use, the system can identify M-proteins based on their molecular weight to help diagnose multiple myeloma and related disorders.

NEW YORK – Backed by promising results from a recent small study, Arima Genomics believes that its Hi-C lymphoma assay can eventually replace fluorescence in situ hybridization (FISH)-based tests to ...